Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

TME Pharma AG
Sponsor

TME Pharma AG

Germany Max-Dohrn-Strasse 8-10, Charlottenburg, 10589 Berlin, Germany

About the sponsor

TME Pharma AG focuses on glioblastoma, with clinical interest centered on newly diagnosed disease and unmethylated MGMT promoter status.

  • Glioblastoma
  • Neuro-oncology
  • Newly diagnosed brain tumours

The company’s research activity in this area is directed toward treatment settings that address aggressive central nervous system malignancy.

About Specializations

TME Pharma AG runs clinical trials in conditions such as Glioblastoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Glioblastoma

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:TME Pharma AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.